D.9. Key Learning Outcomes

1. Acquires systematic knowledge, pre-formulation, formulation designs, effects of psychopharmaceutical parameters on release, evaluation of bioavailability and bioequivalancy.

2. Obtains sufficient knowledge about industrial production, quality control, quality assurance systems, the guidelines such as GMP, GLP, GCP, NDA, ANDA, BA/BE, QA/QC and bioanalytical method validation and preparation of new drug application files.

3. Learns preparing application files for animal/human experiments, and the procedures to apply for permission from ethical committees.

4. Learns the proof-based research principles, statistically evaluates the results.

5. Learns the interdisciplinary interactions and the advances and uses it.

6. Acquires information about drug delivery and controlled release systems, learns the using purpose of these systems in targeting, understands and evaluates in vitro and in vivo evaluations of these systems.

7. Defines an existing problem, tests the solution by doing scientific experiments and evaluates the situation.

8. Learns to keep track of up-to-date literature and patent information using the knowledge and informatics technologies. using this knowledge helps in strategy and political planning in the matter of health to look out for country?s best.

9. Learns to operate the instruments which are needed to be used in scientific research.

10. Can work in a group, can complete and report work that given by the project executor.

11. Can easily reach the guidelines of health authorities such as FDA, EMA and WHO, and gains the ability in the application of those guidelines.